Guidance for developing phase II cell therapy trial proposals for consideration by the Blood and Marrow Transplant Clinical Trials Network. Biol Blood Marrow Transplant 2011 Feb;17(2):192-6
Date
12/25/2010Pubmed ID
21182973Pubmed Central ID
PMC3387575DOI
10.1016/j.bbmt.2010.08.020Scopus ID
2-s2.0-79251497333 (requires institutional sign-in at Scopus site) 1 CitationAuthor List
Horwitz EM, Horowitz MM, DiFronzo NL, Kohn DB, Heslop HE, Blood and Marrow Transplant Clinical Trials Network, State of the Science Cell and Gene Therapy CommitteeAuthor
Mary M. Horowitz MD, MS Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Bone Marrow TransplantationClinical Trials, Phase II as Topic
Cord Blood Stem Cell Transplantation
Evidence-Based Medicine
Hematopoietic Stem Cell Transplantation
Humans
Multicenter Studies as Topic
National Cancer Institute (U.S.)
National Heart, Lung, and Blood Institute (U.S.)
Peripheral Blood Stem Cell Transplantation
Research Design
Research Support as Topic
United States